Neuberger Berman Group’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-52,276
Closed -$813K 1738
2018
Q1
$813K Sell
52,276
-5,368
-9% -$95.7K ﹤0.01% 1245
2017
Q4
$1.09M Buy
57,644
+49,904
+645% +$1.11M ﹤0.01% 1172
2017
Q3
$226K Sell
7,740
-16
-0.2% -$473 ﹤0.01% 1496
2017
Q2
$250K Sell
7,756
-8,340
-52% -$274K ﹤0.01% 1463
2017
Q1
$557K Sell
16,096
-585
-4% -$20.9K ﹤0.01% 1282
2016
Q4
$589K Buy
16,681
+506
+3% +$17.1K ﹤0.01% 1259
2016
Q3
$562K Buy
16,175
+6,004
+59% +$210K ﹤0.01% 1244
2016
Q2
$380K Sell
10,171
-735
-7% -$27.6K ﹤0.01% 1317
2016
Q1
$441K Buy
10,906
+23
+0.2% +$857 ﹤0.01% 1288
2015
Q4
$392K Buy
10,883
+3,783
+53% +$137K ﹤0.01% 1332
2015
Q3
$227K Hold
7,100
﹤0.01% 1420
2015
Q2
$241K Hold
7,100
﹤0.01% 1458
2015
Q1
$240K Hold
7,100
﹤0.01% 1488
2014
Q4
$249K Hold
7,100
﹤0.01% 1506
2014
Q3
$232K Hold
7,100
﹤0.01% 1531
2014
Q2
$241K Sell
7,100
-400
-5% -$13.7K ﹤0.01% 1569
2014
Q1
$263K Hold
7,500
﹤0.01% 1465
2013
Q4
$274K Hold
7,500
﹤0.01% 1455
2013
Q3
$259K Hold
7,500
﹤0.01% 1446
2013
Q2
$254K Buy
+7,500
New +$249K ﹤0.01% 1438

Other funds holding ACH

Neuberger Berman Group's ACH Position: Q2 2018 in Review

Neuberger Berman Group sold out of Accendra Health (ACH) in Q2 2018, closing a stake of 52,276 shares — an estimated $813K sold.

Neuberger Berman Group first reported a position in ACH in Q2 2013 and held it in 20 quarters. The position peaked at $1.09M in Q4 2017. 229 funds tracked by Wall St. Rank hold ACH as of Q2 2018.

  • Neuberger Berman Group reported no remaining Accendra Health position as of Q2 2018 after selling out during the quarter.
  • Neuberger Berman Group sold 52,276 Accendra Health shares in Q2 2018, an estimated $813K.
  • Neuberger Berman Group first reported a position in Accendra Health in Q2 2013 and held it in 20 quarters.
  • Neuberger Berman Group's Accendra Health position peaked at $1.09M in Q4 2017.
  • 229 funds tracked by Wall St. Rank held Accendra Health as of Q2 2018.

Based on Neuberger Berman Group's 13F filing for Q2 2018, filed 13 Aug 2018.